We document the molecular docking and GC-MS data for the inhibition of RAD51 expression by 1,2,4-Trimethyl-3-nitrobicyclo [3.3.1] nonan-9-one from C. inerme in the context of pancreatic cancer drug discovery. This evidence concerns the gene RAD51 and familial pancreatic carcinoma.